Control of High Prescription Drug Costs
Finding a balance between drug affordability, access, and innovation remains a critical challenge.
Finding a balance between drug affordability, access, and innovation remains a critical challenge.
Advanced analytics are enabling proactive and targeted population health management strategies.
Telehealth growth is more targeted and specialized.
Voice-activated systems are becoming more prevalent.
Clinicians' trust in AI is revolutionizing diagnosis and treatment planning.
Consumer-facing digital technologies continue to rise.
Risk arrangements in the commercial market are accelerating.
AI will continue expanding across the healthcare continuum, with momentum building in the front office.
Digital therapeutics (DTx) are expanding into new domains like oncology, women's health and pediatrics.
Employers are directly contracting with healthcare providers to manage rising healthcare costs.
Healthcare transparency will continue to be a priority for federal policymakers.
2025 will see an emphasis on flexible health insurance options.